Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07175532

Prospective Multicenter Registry of Patients With Mitral Stenosis Undergoing Percutaneous Mitral Balloon Commissurotomy

The goal of this observational study is to learn about the clinical outcomes after percutaneous mitral balloon commissurotomy (PMBC) for patients with mitral stenosis (MS) using nation-wide multicenter prospective registry including tertiary-referral hospitals in Korea.

The main question it aims to answer is:

What is the clinical outcomes after PMBC? Which method is appropriate to determine inflated Inoue balloon size?

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–89 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with mitral stenosis undergoing PMBC

Exclusion criteria

  • Patients who cannot understand this study due to mental illness
  • Serious comorbidity limiting life expectancy within 1 year
  • Limited activity (NYHA class III or IV) due to non-cardiac disease

Treatment and study plan

Primary outcomes

  1. Number of Participants with Treatment-Related Adverse Events

    Time frame: From enrollment to 1 year after PMBC

Study contacts

Contact information is provided by the study sponsor or research team.

Jong-Min Song

CONTACT

[email protected]

82230103168

Sponsors and collaborators

Lead sponsor

Asan Medical Center

Other

Registry information

Important dates

Study start
2025
Primary completion
2031
Study completion
2031
First posted
Sep 16, 2025
Registry last updated
Sep 16, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.